Workflow
Pacific Biosciences of California(PACB) - 2025 Q3 - Quarterly Results

Third quarter results: | | Q3 2025 | Q3 2024 | | --- | --- | --- | | Revenue | 38.4million38.4 million | 40.0 million | | Instrument revenue | 11.3million11.3 million | 16.8 million | | Consumable revenue | 21.3million21.3 million | 18.5 million | | Service and other revenue | 5.8million5.8 million | 4.7 million | | TM Revio systems | 13 | 22 | | TM Vega systems | 32 | — | | Annualized Revio pull-through per system | ~236,000 236,000 | ~255,000 | | Cash, cash equivalents, and investments | 298.7million298.7 million | 471.1 million | Gross margin, operating ...